- Home
- SND vs MNOV Comparison
SND vs MNOV Comparison
Compare SND & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- MNOV
- Stock Information
- Founded
- SND 2011
- MNOV 2000
- Country
- SND United States
- MNOV United States
- Employees
- SND N/A
- MNOV N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- MNOV Health Care
- Exchange
- SND Nasdaq
- MNOV Nasdaq
- Market Cap
- SND 104.7M
- MNOV 87.3M
- IPO Year
- SND 2016
- MNOV 2005
- Fundamental
- Price
- SND $2.32
- MNOV $1.86
- Analyst Decision
- SND Hold
- MNOV
- Analyst Count
- SND 2
- MNOV 0
- Target Price
- SND $2.63
- MNOV N/A
- AVG Volume (30 Days)
- SND 248.6K
- MNOV 133.9K
- Earning Date
- SND 11-12-2024
- MNOV 11-22-2024
- Dividend Yield
- SND N/A
- MNOV N/A
- EPS Growth
- SND N/A
- MNOV N/A
- EPS
- SND N/A
- MNOV N/A
- Revenue
- SND $281,957,000.00
- MNOV $1,000,000.00
- Revenue This Year
- SND N/A
- MNOV N/A
- Revenue Next Year
- SND N/A
- MNOV N/A
- P/E Ratio
- SND N/A
- MNOV N/A
- Revenue Growth
- SND N/A
- MNOV N/A
- 52 Week Low
- SND $1.65
- MNOV $1.12
- 52 Week High
- SND $2.80
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- SND 53.97
- MNOV 57.75
- Support Level
- SND $2.14
- MNOV $1.49
- Resistance Level
- SND $2.80
- MNOV $2.55
- Average True Range (ATR)
- SND 0.15
- MNOV 0.17
- MACD
- SND 0.02
- MNOV 0.05
- Stochastic Oscillator
- SND 40.00
- MNOV 50.00
About SND Smart Sand Inc.
Smart Sand Inc is a fully integrated frac sand supply and services company that offers complete mine-to-well site proppant supply and logistics solutions. It produces Northern White frac sand, which is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Its product portfolio includes Smart System, which includes SmartBelt, SmartDepot Silo and SmartPath Loader. The company caters its products and services to oil and natural gas exploration and production companies and oilfield service companies. The majority of its revenue comes from Sand Sales, followed by logistics.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.